Literature DB >> 19648516

A hypothesis for the initiation of COPD.

E G Tzortzaki1, N M Siafakas.   

Abstract

Chronic obstructive pulmonary disease (COPD) is generally thought to depend on an aberrant immune response to a noxious or infectious agent, which may cause chronic inflammation. However, the initiation of this abnormal response is not fully understood. Here, we propose a new hypothesis for the beginning of COPD, that the immune response to inhaled agents, mainly cigarette smoke, is directed toward the airway epithelium, due to oxidative DNA damage of the lung epithelial barrier cells (LEBCs). The steps of this model are as follows. 1) Cigarette smoke induces oxidative DNA damage of LEBCs. 2) The acquired mutations are expressed at the microsatellite DNA level of LEBCs. 3) The altered LEBCs are recognised by dendritic cells (DCs) as "nonself". DCs travel, with the new information, to the lymph nodes, presenting it to the naïve T-lymphocytes. 4) A predominant CD8+ cytotoxic T-lymphocyte proliferation occurs. The CD8+ cells, by releasing perforin and granzymes, attack the altered LEBCs activating cell death cascades. Obviously, the above scenario needs further experimental exploration. However, it is an attractive model for the initiation of the abnormal inflammation in COPD, comprising oxidative DNA damage of LEBCs and host immune response.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19648516     DOI: 10.1183/09031936.00067008

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  14 in total

1.  CD8+ T cells and risk for bacterial pneumonia and all-cause mortality among HIV-infected women.

Authors:  Shruti K Gohil; Moonseong Heo; Ellie E Schoenbaum; David Celentano; Liise-anne Pirofski
Journal:  J Acquir Immune Defic Syndr       Date:  2012-06-01       Impact factor: 3.731

2.  Enhanced effector function of cytotoxic cells in the induced sputum of COPD patients.

Authors:  Richard A Urbanowicz; Jonathan R Lamb; Ian Todd; Jonathan M Corne; Lucy C Fairclough
Journal:  Respir Res       Date:  2010-06-11

3.  Deregulation of apoptosis mediators' p53 and bcl2 in lung tissue of COPD patients.

Authors:  Marianna Siganaki; Anastasios V Koutsopoulos; Eirini Neofytou; Eleni Vlachaki; Maria Psarrou; Nikolaos Soulitzis; Nikolaos Pentilas; Sophia Schiza; Nikolaos M Siafakas; Eleni G Tzortzaki
Journal:  Respir Res       Date:  2010-04-27

Review 4.  Pulmonary-intestinal cross-talk in mucosal inflammatory disease.

Authors:  S Keely; N J Talley; P M Hansbro
Journal:  Mucosal Immunol       Date:  2011-11-16       Impact factor: 7.313

Review 5.  Mouse models to unravel the role of inhaled pollutants on allergic sensitization and airway inflammation.

Authors:  Tania Maes; Sharen Provoost; Ellen A Lanckacker; Didier D Cataldo; Jeroen A J Vanoirbeek; Benoit Nemery; Kurt G Tournoy; Guy F Joos
Journal:  Respir Res       Date:  2010-01-21

6.  Lung compliance and chronic obstructive pulmonary disease.

Authors:  D Papandrinopoulou; V Tzouda; G Tsoukalas
Journal:  Pulm Med       Date:  2012-10-22

Review 7.  DNA damage due to oxidative stress in Chronic Obstructive Pulmonary Disease (COPD).

Authors:  Eirini Neofytou; Eleni G Tzortzaki; Argiro Chatziantoniou; Nikolaos M Siafakas
Journal:  Int J Mol Sci       Date:  2012-12-10       Impact factor: 5.923

8.  Increased number and altered phenotype of lymphatic vessels in peripheral lung compartments of patients with COPD.

Authors:  Michiko Mori; Cecilia K Andersson; Gerard J Graham; Claes-Göran Löfdahl; Jonas S Erjefält
Journal:  Respir Res       Date:  2013-06-11

Review 9.  Transposable elements and their potential role in complex lung disorder.

Authors:  Muralidharan Sargurupremraj; Matthias Wjst
Journal:  Respir Res       Date:  2013-10-05

10.  Impact of smoking on dendritic cell phenotypes in the airway lumen of patients with COPD.

Authors:  Paul Stoll; Ann-Sophie Heinz; Kai Bratke; Andrea Bier; Katharina Garbe; Michael Kuepper; J Christian Virchow; Marek Lommatzsch
Journal:  Respir Res       Date:  2014-04-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.